Clinical Trial Update: Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update on lowering hyperuricemia to assess cardiovascular outcomes in peritoneal dialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Peritoneal Dialysis-related Cardiovascular Disease

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hyperuricemia | Phase 4 | Status: UNKNOWN